PTHS - Chromocell Therapeutics Corp
23
0.050 0.217%
Share volume: 18,667
Last Updated: 04-21-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$22.95
0.05
0.00%
Summary score
37%
Profitability
43%
Dept financing
43%
Liquidity
42%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-88.98%
Return on sales
17136.59%
Return on invested capital
0%
Total debt ratio
245.71%
Debt ratio change over timeo
0%
Current Ratio
1.14%
Quick Ratio
1.09%
Cash Position Ratio
0.35%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-74.21%
Return on sales
-167.64%
Return on invested capital
0%
Total debt ratio
228.2%
Debt ratio change over timeo
0%
Current Ratio
1.41%
Quick Ratio
1.09%
Cash Position Ratio
0.43%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-9.21%
Return on sales
-127.85%
Return on invested capital
0%
Total debt ratio
70.18%
Debt ratio change over time
0%
Current Ratio
2.05%
Quick Ratio
1.15%
Cash Position Ratio
0.69%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PTHS | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 5.97% | 8.91% |
| Return on assets | -88.98% | 2.97% | 3.34% | 2.04% |
| Return on sales | 17136.59% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | 0% | 0% | 3.51% | 10.25% |
| Profitability | 25% | 22% | 50% | 65% |
| Total debt ratio | 245.71% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | 0% | 14.34% | 187.33% | 9.75% |
| Dept financing | 25% | 11% | 32% | 6% |
| Current Ratio | 1.41% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 1.09% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 0.43% | 0.39% | 0.58% | 0.86% |
| Liquididy | 40% | 63% | 50% | 73% |
| Short-term ratios | PTHS | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -74.21% | 3.27% | 4.7% | 1.36% |
| Return on sales | -167.64% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 228.2% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 10% | 7% | 4% |
| Current Ratio | 1.41% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 1.09% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 0.43% | 0.39% | 0.58% | 0.86% |
| Liquididy | 43% | 38% | 51% | 75% |